This joint resolution from the Montana Legislature requests an interim study to examine the prescription drug supply chain, focusing on pharmacy sustainability and the impacts on affordability and patient access. The study aims to analyze the roles and relationships of various stakeholders, including pharmacies, manufacturers, and health plans, and how these dynamics influence pharmacy operations and patient access to medications. It will also identify factors affecting pharmacy openings and closures, explore strategies to reduce patient costs, and assess best practices from other states regarding prescription drug affordability.

The resolution emphasizes the importance of transparency and stakeholder engagement throughout the study process, ensuring that all data used is aggregated, publicly available, or voluntarily provided. It mandates that the study's findings and recommendations be presented to an appropriate committee and reported to the 70th Legislature by September 15, 2026. The recommendations must address improvements in patient access, cost impacts, and the sustainability of independent pharmacies.